17.42BMarket Cap66.56P/E (TTM)
10.93High10.61Low158.95KlotVolume10.81Open10.87Pre Close171.49MTurnover1.02%Turnover Ratio41.57P/E (Static)1.61BShares28.4452wk High1.88P/B16.99BFloat Cap10.6152wk Low13.04Limit Up1.57BShs Float96.68Historical High8.70Limit Down2.94%Amplitude3.57Historical Low0.01Dividend TTM10.79Avg Price80.52KlotAsk0.09%Div YieldTTM100Lot Size74.34KlotBid
Walvax Biotechnology Stock Forum
$Sinovac Biotech(SVA.US)$ $FOSUN PHARMA(02196.HK)$ $Shanghai Fosun Pharmaceutical(600196.SH)$ $CanSino Biologics Inc.(688185.SH)$ $CANSINOBIO(06185.HK)$ $Walvax Biotechnology(300142.SZ)$ $Chongqing Zhifei Biological Products(300122.SZ)$
1. Foreign phase iii, will start playing soon. We've been saying we're not fighting, but now we're saying we're fighting.
2. The second phase of the domestic has been played down, specific whether there are adverse reactions, the other party to see the test data. But the other party said that their colleague had been inactivated, and some adverse reactions were also many, such as vomiting and diarrhea.
Today's big drop may be a collective kill for the so-called track stocks. Good stocks will soon come back.
...
...
To prevent infection, Pfizer effective rate 79%, Chinese medicine 45%;
Prevention of hospitalization, Pfizer effective rate of 94%, Chinese medicine 44%;
The effective rate of Pfizer was 99% and sinopharm 64%.
Prevent death, Pfizer effective rate 95%, 63%.) $Walvax Biotechnology(300142.SZ)$ $Shenzhen Kangtai Biological Products(300601.SZ)$
[AIDS vaccine enters human experimental stage]
▲Moderna AIDS vaccine will start human trials on August 19 and is expected to be completed in the spring of 2023, using mRNA technology similar to the new crown vaccine.
▲Moderna has two candidate HIV vaccines, mRNA-1644 and mRNA-1644v2-Core. These two vaccines have passed preliminary safety tests before they were first used in humans.
▲The new crown epidemic has accelerated the maturity of mRNA vaccine technology, and this technology is also a technology that can achieve mass production as soon as possible. Several other companies are also developing AIDS vaccines. Some candidate vaccines are currently or are about to enter clinical trials.
Looking forward to Watson's breakthroughs in other infectious diseases, just do international mRNA fast-follow.
...
The firm has cooperated with Tsinghua University and Tianjin Medical University.
$Walvax Biotechnology(300142.SZ)$
No comment yet